Covid-19 and pulmonary thromboembolism: a case report
DOI:
https://doi.org/10.31686/ijier.vol10.iss7.3806Keywords:
SARS-CoV-2, pandemic disease, pulmonary thromboembolismAbstract
COVID-19 is an acute viral infection caused by SARS-CoV-2 coronavirus. This pandemic disease stands out for the marked variation in the clinical characteristics of patients, ranging from asymptomatic cases to severe organ dysfunction and death. Serious complications occur in the late phase of the disease or even after viral infection, and thrombotic events are one of these complications. In this context, this study aimed to report a case of an obese, young adult female patient with a complication of pulmonary thromboembolism after infection by COVID-19.
Downloads
References
Cabral, R.B.G. et al. Estudo inicial sobre a evolução do novo CORONAVÍRUS (SARS-COV-2) no estado do Pará (Brasil), no período entre 17/03/2020 e 06/04/2020. Brazilian Journal of Health Review, v. 3, n. 2, p. 2914-2931, 2020. DOI: https://doi.org/10.34119/bjhrv3n2-133
Largura, T. S. Análise do impacto da pandemia de Covid-19 no setor de comércio em Santa Catarina. TCC (graduação) - Universidade Federal de Santa Catarina. Centro Sócio-Econômico. Economia, 2022.
Ioannidis J.P.A., Coronavirus disease 2019: the harms of exaggerated information and nonevidence-based measures. Eur J Clin Invest,v. 50, e: 13222, 2020. DOI: https://doi.org/10.1111/eci.13222
Matta, G.C., Rego, S., Souto, E.P., And Segata, J., Eds. Os impactos sociais da Covid-19 no Brasil: populações vulnerabilizadas e respostas à pandemia [online]. Rio de Janeiro: Observatório Covid 19; Editora FIOCRUZ, 2021, 221 p DOI: https://doi.org/10.7476/9786557080320
CastroL. F. da S. O.; SilvaA. L. da; LimaM. A. de, et al. Influenza e SARS-CoV-2: distinção clínica e imunopatológica no decorrer da pandemia da Covid-19. Revista Eletrônica Acervo Saúde, v. 15, n. 3, p. e9963, 28 mar. 2022. DOI: https://doi.org/10.25248/reas.e9963.2022
Franco C.G., Rodrigues E.C.A., Nascimento N.S, et al. Infecção Por Coronavírus (Sars-Cov-2) Em Recém-Nascido Em Uma Maternidade Municipal Em Goiânia-Go. The Brazilian Journal of Infectious Diseases. Volume 26, Supplement 1, January 2022, 102034 DOI: https://doi.org/10.1016/j.bjid.2021.102034
FILHO, A. D. S.F., Indicação E Uso Da Azitromicina No Tratamento Da Covid-19: Uma Revisão Integrativa. Mamografia apresentada ao Curso de Bacharelado de Farmácia da Faculdade de Enfermagem Nova Esperança do Mossoró (FACENE), 2021.
World Health Organization (WHO). Frequently asked questions on Middle East respiratory syndrome coronavirus (MERS‐CoV). Disponível em: https://www.cdc.gov/coronavirus/mers/faq.html.
Yang X., Yu Y., Xu J., et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a singlecentered, retrospective, observational study. Lancet Respir Med., v. 8, n.4, e:26, 2020.
SOBREIRA, M.L.; MARQUES, M.A., A panaceia dos anticoagulantes na infecção pela COVID-19. J. vasc. bras. v.19, p. 1-2, 2020. DOI: https://doi.org/10.1590/1677-5449.200063
Zhai Z., Li C., Chen Y., et al. Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines. Thromb Haemost, v. 120, n. 06, p. 937-948, 2020. DOI: https://doi.org/10.1055/s-0040-1710019
RODRIGUES, B. A.; NUNES, C.P., Covid-19 E Tromboembolismo Pulmonar. Revista da Faculdade de Medicina de Teresópolis, v. 5, n. 1, 2022.
Hana H., Yanga L., Liu R., et al. Prominent changes in blood coagulation of patients with SARS-CoV-2 infection; Clin Chem Lab Med, v. 58, n. 7, p. 1116-1120, 2020. DOI: https://doi.org/10.1515/cclm-2020-0188
Farhat F.G.L.C., Gregório H.C.T., Carvalho R.D.P., Avaliação da profilaxia da trombose venosa profunda em um hospital geral. J Vasc Bras., v. 17, n. 3, p. 184-192, 2018. DOI: https://doi.org/10.1590/1677-5449.007017
LOBASTOV, K., et al. Prediction of Symptomatic Venous Thromboembolism in Covid-19 Patients: A Retrospective Comparison of Caprini, Padua, and IMPROVE-DD Scores. Journal of Vascular Surgery: Venous and Lymphatic Disorders, v. 10, n. 2, p. 572-573, 2022. DOI: https://doi.org/10.1016/j.jvsv.2021.12.062
Rodrigues, R.R., Correia, T., Guimarães H.P., et al. Recomendações sobre Manejo da Anticoagulação nos Pacientes com COVID-19. Associação Brasileira de Medicina de Emergência, 2020.
Gage B.F., Yan Y., Milligan P.E., et al. Clinical Classification Schemes for Predicting Hemorrhage: Results From the National Registry of Atrial Fibrillation (NRAF); Am Heart J. 2006 Mar;151(3):713-9. doi: 10.1016/j.ahj.2005.04.017. DOI: https://doi.org/10.1016/j.ahj.2005.04.017
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Dora Inés Kozusny-Andreani, Nara Moraes Guimarães, Letícia Martins Bertati, Milena Ferreira Bessa, Bruna Pereira, Márcio César Reino Gaggini, Anna Gabrielly Macias, Vitor Hugo Ramos Alves, Maísa Stefani Lemes Pelarim, Vanessa Cristina Machado Both, Jamili Namara Freitas de Melo, Maurício Fernando Favaleça
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyrights for articles published in IJIER journals are retained by the authors, with first publication rights granted to the journal. The journal/publisher is not responsible for subsequent uses of the work. It is the author's responsibility to bring an infringement action if so desired by the author for more visit Copyright & License.
How to Cite
Accepted 2022-06-24
Published 2022-07-01
